NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr | ₹152 Cr |
What is the latest Revenue of NGL FINECHEM ?
Year | Revenue |
---|---|
Mar2024 | ₹339 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹318 Cr |
Mar2021 | ₹258 Cr |
Mar2020 | ₹152 Cr |
How is Revenue of NGL FINECHEM Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹339 Cr | 21.79 | |
Mar2023 | ₹278 Cr | -12.42 | |
Mar2022 | ₹318 Cr | 23.08 | |
Mar2021 | ₹258 Cr | 70.07 | |
Mar2020 | ₹152 Cr | - |
Compare Revenue of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,141.8 Cr | 11.1% | 5.2% | -12.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 11.1% |
5.2% |
-12.2% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses